BAYMEDICA
BayMedica is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry to develop an efficient, scalable, and proprietary platform.
BAYMEDICA
Social Links:
Industry:
Biotechnology Cannabis Health Care Medical Wellness
Founded:
2016-01-01
Address:
Incline Village, Nevada, United States
Country:
United States
Website Url:
http://www.baymedica.com
Total Employee:
1+
Status:
Active
Contact:
(650) 392-0510
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving CrUX Top 50m CrUX Dataset Pound Sterling
Similar Organizations
Aggamin Biologics
Aggamin Biologics is a biotechnology company developing biologic drugs for unmet medical needs.
Arcana Biotech HOLDINGS INC
Hemp company with focus on organic CBD products
Cannformatics
Biotechnology
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Geocann
Geocann is a biotechnology company that specializes in global cannabis drug manufacturing, clinical tested, and product research services.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Tradewind BioScience
Tradewind BioScience is a biotechnology company developing antibody therapeutics for ovarian cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.baymedica.com Semrush global rank: 3.33 M Semrush visits lastest month: 4.2 K
- Host name: 162.223.226.26
- IP address: 162.223.226.26
- Location: Vancouver Canada
- Latitude: 49.245
- Longitude: -123.1337
- Timezone: America/Vancouver
- Postal: V6H

More informations about "BayMedica"
BayMedica - Crunchbase Company Profile & Funding
BayMedica is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry. View contacts for BayMedica to access new leads and connect with …See details»
BayMedica - LinkedIn
BayMedica Inc., a division of InMed Pharmaceuticals (Nasdaq: INM) is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry to develop …See details»
InMed Pharmaceuticals Completes Acquisition of BayMedica …
Acquisition overview and amended transaction terms: InMed acquired 100% of BayMedica in exchange for 2.05 million InMed common shares issued to BayMedica’s equity and convertible …See details»
InMed Provides Update on BayMedica Rare Cannabinoid Business
BayMedica is a leading high quality, low cost supplier of non-intoxicating bioidentical rare cannabinoids for the H&W sector: cannabichromene (CBC), delta-9 tetrahydrocannabivarin …See details»
BayMedica Company Profile 2024: Valuation, Investors ... - PitchBook
BayMedica was founded in 2016. Where is BayMedica headquartered? BayMedica is headquartered in Vancouver, Canada. What is the size of BayMedica? BayMedica has 9 total …See details»
BayMedica - Products, Competitors, Financials, Employees, …
BayMedica is a scalable biosynthetic platform delivering natural cannabinoids including CBC, CBD, and CBG as well as novel cannabinoid analogs. The company is creating an efficient, …See details»
BayMedica, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BayMedica, LLC of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
BayMedica - Contacts, Employees, Board Members, Advisors
BayMedica is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry.See details»
InMed Pharmaceuticals Signs Definitive Agreement to Acquire …
Pursuant to the indicative terms of the Definitive Agreement, InMed will acquire 100% of BayMedica in exchange for 1.78 million InMed common shares, to be issued to BayMedica’s …See details»
InMed Provides Update on BayMedica Rare Cannabinoid Business
Jul 20, 2023 BayMedica is a leading high quality, low cost supplier of non-intoxicating bioidentical rare cannabinoids for the H&W sector: cannabichromene (CBC), delta-9 …See details»
InMed Pharmaceuticals Signs Definitive Agreement to Acquire …
Sep 13, 2021 InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids InMed Pharmaceuticals Inc. Mon, …See details»
BayMedica | CipherBio
Explore BayMedica's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Our Team | Cannabinoid Biosynthesis Scientists - BayMedica
Most recently he ran operations for Kzen California, a cannabis beverage company. Previously, Mr. Cacheiro spent 15 years with Pfizer, most recently as a Senior Manager of Operational …See details»
BayMedica | BayMedica
By bmi_wpadmin | Sep 23, 2024 | BayMedica, Research. The cannabis industry has moved one step closer to discovering the perfect, non-intoxicating therapeutic solution for bodily …See details»
InMed Pharmaceuticals Signs Non-binding Letter of Intent to …
Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange …See details»
FAQ | BayMedica
Baymedica’s manufacturing process creates cannabinoid molecules that are bioidentical to those found in nature. How do endocannabinoids work? Cannabinoids produce their effects by …See details»
InMed Pharmaceuticals Completes Acquisition of BayMedica
Oct 13, 2021 About BayMedica: BayMedica Inc. is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry to develop an efficient, scalable, …See details»
Latest Product News and Updates - BayMedica
Stay up-to-date with the latest product news and updates from Bay Medica. Discover new advancements, innovations, and releases in the medical field.See details»
BayMedica’s Innovative Cannabinoid Synthesis Platform | Pure, …
At BayMedica, we’ve developed a patent-pending precision-fermentation manufacturing platform that transforms common brewer’s yeast into a biological factory for rare cannabinoids. …See details»